We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

CGI Receives NY State Approval for NGS Lymphoma Panel

News   Jul 02, 2016

 
CGI Receives NY State Approval for NGS Lymphoma Panel
 
 
 

RELATED ARTICLES

Test Which Identifies Drug-resistant Tuberculosis Bacteria Now Available In Europe

News

Now available in Europe: A diagnostic test which can simultaneously detect tuberculosis-causing bacteria and determine if the bacteria contain mutations associated with resistance to two important first line drugs.

READ MORE

5.1 Million Dollar Funding Boost for Blinding Retinal Conditions

News

A $5.1 million grant has been awarded from the California Institute for Regenerative Medicine to advance the development of a novel therapy for blinding retinal conditions.

READ MORE

Drug Could Sustain Oxygen-Starved Hearts

News

In new studies a novel oxygen-delivery therapeutic restored the function of oxygen-starved heart tissue in an animal model of global hypoxia. Unlike its experimental predecessors, the new drug does not appear to cause systemic side effects or overcorrect with excessive blood oxygenation, which can itself be toxic. Instead, the new drug delivers its precious oxygen cargo only to the tissues that need it most.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE